Showing results (91-100 of 403) with videos related to
Sort By:
Pageof 41
Biorxiv : the Preprint Server for Biology|June 19, 2024
IMMUNOTAR - Integrative prioritization of cell surface targets for cancer immunotherapyRawan Shraim, Brian Mooney, Karina L Conkrite, et al.Journal of the National Cancer Institute|February 23, 2019
Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal NeuroblastomaDerek A Oldridge, Bao Truong, Douglas Russ, et al.Journal of the National Cancer Institute|February 8, 2022
Identification of Mitochondrial DNA Variants Associated With Risk of NeuroblastomaXiao Chang, Yichuan Liu, Joseph Glessner, et al.Pediatric Blood & Cancer|September 5, 2009
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitroHolly J Meany, Dan L Sackett, John M Maris, et al.Bioinformatics (Oxford, England)|February 11, 2025
ImmunoTar-integrative prioritization of cell surface targets for cancer immunotherapyRawan Shraim, Brian Mooney, Karina L Conkrite, et al.Genes, Chromosomes & Cancer|July 25, 2007
Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expressionYael P Mosse, Sharon J Diskin, Nora Wasserman, et al.Genome Research|August 11, 2006
STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experimentsSharon J Diskin, Thomas Eck, Joel Greshock, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group studyLisa A Moreau, Patrick McGrady, Wendy B London, et al.Cell Cycle (Georgetown, Tex.)|February 21, 2014
Inactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cellsYuko Murakami-Tonami, Satoshi Kishida, Ichiro Takeuchi, et al.Biorxiv : the Preprint Server for Biology|December 18, 2023
Advancing childhood cancer research through young investigator and advocate collaborationAmber K Weiner, Antonia Palmer, Melanie Frost Moll, et al.Pageof 41